天目药业 (600671)

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.

ASH

Tags

New QFII HoldingsTraditional Chinese MedicineLong-Term Non-Dividend PayersPharmaceutical ManufacturingPharmaceuticals and HealthcareShell ResourcesSmall Cap State-Owned EnterprisesSmall Cap Non-FinancialMicro Cap Selected StocksMicro Cap StocksDelisting Warning RemovalNew Private Equity HoldingsHigh Price-to-Book Ratio

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 12177.89
  • Circulating A-Shares(W): 12172.05
  • Earnings Per Share(RMB): 0.1167
  • Net Assets Per Share(RMB): 0.5468
  • Operating Revenue(W RMB): 15894.04
  • Total Profit(W RMB): 1000.12
  • **Net Profit Attributable to Parent(W RMB) **: 1420.88
  • Net Profit Growth Rate(%): 484.48
  • Weighted Return on Equity(%): 23.8900
  • Operating Cash Flow Per Share(RMB): -0.2530
  • Undistributed Profit Per Share(RMB): -1.9885
  • Capital Reserve Per Share(RMB): 1.3367

2. Main Business

The main business covers:

  • Sales of pharmaceuticals and related healthcare products

3. Company Basic Information

  • Company Name: Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd.
  • Listing Date: 1993-08-23
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 18 Shangyang Road, Jinnan Street, Lin'an District, Hangzhou City, Zhejiang Province
  • Website: https://www.hztmyy.com/
  • Company Profile: The company's predecessor was Hangzhou Tianmu Mountain Pharmaceutical Factory, which underwent a joint-stock restructuring in 1989, initially converting the factory's net assets into 45,000 shares of corporate shares with a face value of 100 RMB and 20,000 individual shares. In June 1992, it implemented a standardized joint-stock restructuring, converting the net asset value appreciation into 40,000 shares, bringing the total shares to 10.50 million. After the initial public offering in February 1993 and the additional issuance of corporate shares and preferred shares of 18.90 million shares in May of the same year, the total number of shares at the time of listing was 50.40 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Qingdao Huilong Huaze Investment Co., Ltd. General Legal Person 3651.95 30.00
2 Qingdao Yuanjia Medical Technology Co., Ltd. General Legal Person 1616.00 13.28
3 Zhejiang Qingfeng Yuansheng Culture Co., Ltd. General Legal Person 518.18 4.26
4 Hangzhou Yuedianrun Investment Management Partnership (Limited Partnership) General Legal Person 500.00 4.11
5 Beijing Heyi Yingtong Asset Management Co., Ltd. - Heyi Huxuan Value No. 1 Private Securities Investment Fund Private Securities Investment Fund 71.72 0.59
6 UBS AG QFII 55.76 0.46

5. Concept Sectors

  • Micro-cap Stocks
  • High Price-to-Book Ratio
  • Delisting Risk Removal (Hat Removal)
  • Long-Term No Dividends
  • Shell Resource
  • QFII New Entry
  • Small Cap Non-Margin
  • Small Cap State-Owned Enterprise
  • Micro-cap Selection
  • Private Placement New Entry

Remarks

  • Data update date: 2025-11-03
  • Data source: Public Market Information